Federal Register / Vol. 79, No. 168 / Friday, August 29, 2014 / Notices 51565 

FEDERAL MARITIME COMMISSION 

Ocean Transportation Intermediary 

License Revocations and Terminations 

The Commission gives notice that the 

following Ocean Transportation 

Intermediary licenses have been 

revoked or terminated for the reason 

indicated pursuant to section 19 of the 

Shipping Act of 1984 (46 U.S.C. 40101) 

effective on the date shown. 

License No.: 004264F. 

Name: Trans Freight Services, Inc. 

Address: 420 Doughty Blvd., 2nd 

Floor, Inwood, NY 11096. 

Date Revoked: August 8, 2014. 

Reason: Failed to maintain a valid 

bond. 

License No.: 017342N. 

Name: Trans Circle Inc. 

Address: 1927 West 139th Street, 

Gardena, CA 90249. 

Date Revoked: August 13, 2014. 

Reason: Failed to maintain a valid 

bond. 

License No.: 022610NF. 

Name: Ascend Logistics, LLC. 

Address: 75 Windsor Pond Road, 

West Windsor, NJ 08550. 

Date Surrendered: August 6, 2014. 

Reason: Voluntary surrender of 

license. 

License No.: 023371N. 

Name: PME Logistics Inc. 

Address: 19401 S. Main Street, Suite 

102, Gardena, CA 90248. 

Date Revoked: August 10, 2014. 

Reason: Failed to maintain a valid 

bond. 

License No.: 024464N. 

Name: Seahorse Forwarding Ltd. 

Address: One Euclid Road, Fort Lee, 

NJ 07024. 

Date Surrendered: August 11, 2014. 

Reason: Voluntary surrender of 

license. 

Sandra L. Kusumoto, 

Director, Bureau of Certification and 

Licensing. 

[FR Doc. 2014–20570 Filed 8–28–14; 8:45 am] 

BILLING CODE 6730–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Diabetes Mellitus Interagency 

Coordinating Committee Meeting 

SUMMARY: The Diabetes Mellitus 

Interagency Coordinating Committee 

(DMICC) will hold a meeting on 

September 29, 2014. The topic for this 

meeting will be ‘‘Implementing the 

Department of Health and Human 

Services National Action Plan for 

Hypoglycemic Safety.’’ The meeting is 

open to the public. 

DATES: The meeting will be held on 

September 29, 2014 from 8:15 a.m. to 

4:00 p.m. Individuals wanting to present 

oral comments must notify the contact 

person at least 10 days before the 

meeting date. 

ADDRESSES: The meeting will be held in 

Building 31 Conference Room 6C6, on 

the NIH Campus in Bethesda, MD. 

FOR FURTHER INFORMATION CONTACT: For 

further information concerning this 

meeting, see the DMICC Web site, 

www.diabetescommittee.gov, or contact 

Dr. B. Tibor Roberts, Executive 

Secretary of the Diabetes Mellitus 

Interagency Coordinating Committee, 

National Institute of Diabetes and 

Digestive and Kidney Diseases, 31 

Center Drive, Building 31A, Room 

9A19, MSC 2560, Bethesda, MD 20892– 

2560, telephone: 301–496–6623; FAX: 

301–480–6741; email: dmicc@

mail.nih.gov. 

SUPPLEMENTARY INFORMATION: The 

DMICC, chaired by the National 

Institute of Diabetes and Digestive and 

Kidney Diseases (NIDDK) comprising 

members of the Department of Health 

and Human Services and other federal 

agencies that support diabetes-related 

activities, facilitates cooperation, 

communication, and collaboration on 

diabetes among government entities. 

DMICC meetings, held several times a 

year, provide an opportunity for 

Committee members to learn about and 

discuss current and future diabetes 

programs in DMICC member 

organizations and to identify 

opportunities for collaboration. The 

September 29, 2014 DMICC meeting 

will focus on ‘‘Implementing the 

Department of Health and Human 

Services National Action Plan for 

Hypoglycemic Safety.’’ 

Any member of the public interested 

in presenting oral comments to the 

Committee should notify the contact 

person listed on this notice at least 10 

days in advance of the meeting. 

Interested individuals and 

representatives or organizations should 

submit a letter of intent, a brief 

description of the organization 

represented, and a written copy of their 

oral presentation in advance of the 

meeting. Only one representative of an 

organization will be allowed to present; 

oral comments and presentations will be 

limited to a maximum of 5 minutes. 

Printed and electronic copies are 

requested for the record. In addition, 

any interested person may file written 

comments with the Committee by 

forwarding their statement to the 

contact person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Because of time constraints for the 

meeting, oral comments will be allowed 

on a first-come, first-serve basis. 

Members of the public who would 

like to receive email notification about 

future DMICC meetings should register 

for the listserv available on the DMICC 

Web site, www.diabetescommittee.gov. 

Date: August 22, 2014. 

B. Tibor Roberts, 

Executive Secretary, DMICC, Office of 

Scientific Program and Policy Analysis, 

National Institute of Diabetes and Digestive 

and Kidney Diseases, National Institutes of 

Health. 

[FR Doc. 2014–20620 Filed 8–28–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

intention of the Agency for Healthcare 

Research and Quality (AHRQ) to request 

that the Office of Management and 

Budget (OMB) approve the proposed 

changes to the currently approved 

information collection project: ‘‘Medical 

Expenditure Panel Survey (MEPS) 

Household Component’’ In accordance 

with the Paperwork Reduction Act, 44 

U.S.C. 3501–3521, AHRQ invites the 

public to comment on this proposed 

information collection. 

DATES: Comments on this notice must be 

received by October 28, 2014. 

ADDRESSES: Written comments should 

be submitted to: AHRQ’s OMB Desk 

Officer by fax at (202) 395–6974 

(attention: AHRQ’s desk officer) or by 

email at OIRA_submission@

omb.eop.gov (attention: AHRQ’s desk 

officer). Copies of the proposed changes 

to questions asked of household 

respondents, data collection 

instruments, collection plans, and 

specific details on the estimated burden 

can be obtained from the AHRQ Reports 

Clearance Officer. 

FOR FURTHER INFORMATION CONTACT: 

Doris Lefkowitz, AHRQ Reports 


wreier-aviles on DSK5TPTVN1PROD with NOTICES
51566 Federal Register / Vol. 79, No. 168 / Friday, August 29, 2014 / Notices 

Clearance Officer, (301) 427–1477, or by 

email at doris.lefkowitzAHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Proposed Project 

Medical Expenditure Panel Survey 

(MEPS) Household Component 

For over thirty years, results from the 

MEPS and its predecessor surveys (the 

1977 National Medical Care 

Expenditure Survey, the 1980 National 

Medical Care Utilization and 

Expenditure Survey and the 1987 

National Medical Expenditure Survey) 

have been used by OMB, DHHS, 

Congress and a wide number of health 

services researchers to analyze health 

care use, expenses and health policy. 

Major changes continue to take place 

in the health care delivery system. The 

MEPS is needed to provide information 

about the current state of the health care 

system as well as to track changes over 

time. The MEPS permits annual 

estimates of use of health care and 

expenditures and sources of payment 

for that health care. It also permits 

tracking individual change in 

employment, income, health insurance 

and health status over two years. The 

use of the National Health Interview 

Survey (NHIS) as a sampling frame 

expands the MEPS analytic capacity by 

providing another data point for 

comparisons over time. 

Households selected for participation 

in the MEPS–HC are interviewed five 

times in person. These rounds of 

interviewing are spaced about 5 months 

apart. The interview will take place 

with a family respondent who will 

report for him/herself and for other 

family members. 

The MEPS–HC has the following goal: 

• To provide nationally 

representative estimates for the U.S. 

civilian noninstitutionalized population 

for health care use, expenditures, 

sources of payment and health 

insurance coverage. 

This study is being conducted by 

AHRQ through its contractor, Westat, 

pursuant to AHRQ’s statutory authority 

to conduct and support research on 

healthcare and on systems for the 

delivery of such care, including 

activities with respect to the cost and 

use of health care services and with 

respect to health statistics and surveys. 

42 U.S.C. 299a(a)(3) and (8); 42 U.S.C. 

299b–2. 

Method of Collection 

To achieve the goals of the MEPS–HC 

the following data collections are 

implemented: 

I. Household Component Core 

Instrument. The core instrument 

collects data about persons in sample 

households. Topical areas asked in each 

round of interviewing include condition 

enumeration, health status, health care 

utilization including prescribed 

medicines, expense and payment, 

employment, and health insurance. 

Other topical areas that are asked only 

once a year include access to care, 

income, assets, satisfaction with health 

plans and providers, children’s health, 

and adult preventive care. While many 

of the questions are asked about the 

entire reporting unit (RU), which is 

typically a family, only one person 

normally provides this information. 

2. Adult Self Administered 

Questionnaire. A brief self-administered 

questionnaire (SAQ) will be used to 

collect self-reported (rather than 

through household proxy) information 

on health status, health opinions and 

satisfaction with health care for adults 

18 and older. The satisfaction with 

health care items are a subset of items 

from the Consumer Assessment of 

Healthcare Providers and Systems 

(CAHPS). The health status items are 

from the Short Form 12 Version 2 (SF– 

12 version 2), which has been widely 

used as a measure of self-reported 

health status in the United States, the 

Kessler Index (K6) of non-specific 

psychological distress, and the Patient 

Health Questionnaire (PHQ–2). 

3. Diabetes Care SAQ. A brief self 

administered paper-and-pencil 

questionnaire on the quality of diabetes 

care is administered once a year (during 

rounds 3 and 5) to persons identified-as 

having diabetes. Included are questions 

about the number of times the 

respondent reported having a 

hemoglobin A1c blood test, whether the 

respondent reported having his or her 

feet checked for sores or irritations, 

whether the respondent reported having 

an eye exam in which the pupils were 

dilated, the last time the respondent had 

his or her blood cholesterol checked and 

whether the diabetes has caused kidney 

or eye problems. Respondents are also 

asked if their diabetes is being treated 

with diet, oral medications or insulin. 

4. Permission forms for the MEPS– 

MPC Provider and Pharmacy Survey. As 

in previous panels of the MEPS, we will 

ask respondents for permission to obtain 

supplemental information from their 

medical providers (hospitals, 

physicians, home health agencies and 

institutions) and pharmacies. 

The MEPS–HC was last approved by 

OMB on December 20th, 2012 and will 

expire on December 31st, 2015. The 

OMB control number for the MEPS–HC 

is 0935–0118. All of the supporting 

documents for the current MEPS–HC 

can be downloaded from OMB’s Web 

site at. http://www.reginfo.gov/public/

do/PRAViewDocument?ref_nbr=201209- 

0935-001 

The MEPS is a multi-purpose survey. 

In addition to collecting data to yield 

annual estimates for a variety of 

measures related to health care use and 

expenditures, the MEPS also provides 

estimates of measures related to health 

status, consumer assessment of health 

care, health insurance coverage, 

demographic characteristics, 

employment and access to health care 

indicators. Estimates can be provided 

for individuals, families and population 

subgroups of interest. Data from the 

MEPS–HC are intended for a number of 

annual reports required to be produced 

by the Agency, including the National 

Health Care Quality Report and the 

National Health Care Disparities Report. 

AHRQ proposes to make the following 

changes to questions asked of 

respondents: 

Additions: 

Closing—questions pertaining to 

respondent email; 

Reenumeration—addition of 

questions pertaining to educational 

level attainment and the determination 

of institutional status; 

Provider Probes—determination if 

healthcare was received in an overnight 

facility; and 

Health Insurance—questions were 

added regarding interaction with the 

health insurance marketplace, 

enrollment through state health 

insurance exchanges, the extent of 

subsidized health insurance, monthly 

premiums, health insurance metal plan 

names, and medical debt. 

Preventive Care—a field test will be 

conducted to assess response loss 

through self-administration. 

Deletions: 

Questions were removed from the 

following sections: Access to Care; 

Closing; Medical Conditions; Charge 

Payment; Child Preventive Health; 

Disability Days; Employment, Health 

Status; Health Insurance; and Income. 

Questions were removed to reduce 

burden and redundancy, additional 

questions were removed due to 

difficulty in respondent interpretation, 

low frequency in response or minimal 

variation, and limited ability of 

respondent to respond accurately. 

Estimated Annual Respondent Burden 

There are no changes to the current 

burden estimates. 

Estimated Annual Costs to the Federal 

Government There are no changes-to the 

current cost estimates. 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 


wreier-aviles on DSK5TPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 168 / Friday, August 29, 2014 / Notices 51567 

information collection are requested 

with regard to any of the following: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ healthcare 

research and healthcare information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: August 20, 2014. 

Richard Kronick, 

Director. 

[FR Doc. 2014–20423 Filed 8–28–14; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: 

Voluntary Relinquishment From 

Patient Safety Services, LLC 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), Department of 

Health and Human Services (HHS). 

ACTION: Notice of Delisting. 

SUMMARY: The Patient Safety and 

Quality Improvement Act of 2005, 42 

U.S.C. 299b–21 to b–26, (Patient Safety 

Act) and the related Patient Safety and 

Quality Improvement Final Rule, 42 

CFR Part 3 (Patient Safety Rule), 

published in the Federal Register on 

November 21, 2008, 73 FR 70732– 

70814, provide for the formation of 

Patient Safety Organizations (PSOs), 

which collect, aggregate, and analyze 

confidential information regarding the 

quality and safety of health care 

delivery. The Patient Safety Rule 

authorizes AHRQ, on behalf of the 

Secretary of NHS, to list as a PSO an 

entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ by 

the Secretary if it is found to no longer 

meet the requirements of the Patient 

Safety Act and Patient Safety Rule, 

when a PSO chooses to voluntarily 

relinquish its status as a PSO for any 

reason, or when a PSO’s listing expires. 

AHRQ has accepted a notification of 

voluntary relinquishment from Patient 

Safety Services, LLC of its status as a 

PSO, and has delisted the PSO 

accordingly. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12:00 Midnight 

ET (2400) on July 30, 2014. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS Web site: http://

www.pso.AHRQ.gov/listed. 

FOR FURTHER INFORMATION CONTACT: 

Eileen Hogan, Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; Email: pso@

AHRQ.hhs.qov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act authorizes the 

listing of PSOs, which are entities or 

component organizations whose 

mission and primary activity are to 

conduct activities to improve patient 

safety and the quality of health care 

delivery. 

HHS issued the Patient Safety Rule to 

implement the Patient Safety Act. 

AHRQ administers the provisions of the 

Patient Safety Act and Patient Safety 

Rule relating to the listing and operation 

of PSOs. The Patient Safety Rule 

authorizes AHRQ to list as a PSO an 

entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ if 

it is found to no longer meet the 

requirements of the Patient Safety Act 

and Patient Safety Rule, when a PSO 

chooses to voluntarily relinquish its 

status as a PSO for any reason, or when 

the PSO’s listing expires. Section 

3.108(d) of the Patient Safety Rule 

requires AHRQ to provide public notice 

when it removes an organization from 

the list of federally approved PSOs. 

AHRQ has accepted a notification 

from Patient Safety Services, LLC, PSO 

number P0129, to voluntarily relinquish 

its status as a PSO. Accordingly, Patient 

Safety Services, LLC was delisted 

effective at 12:00 Midnight ET (2400) on 

July 30, 2014. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/

index.html. 

Dated: August 20, 2014. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2014–20424 Filed 8–28–14; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Scientific Information Request on 

Health Information Exchange 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for Scientific 

Information Submissions. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review of 

Health Information Exchange, which is 

currently being conducted by the 

Evidence-based Practice Centers for the 

AHRQ Effective Health Care Program. 

Access to published and unpublished 

pertinent scientific information will 

improve the quality of this review. 

AHRQ is conducting this systematic 

review pursuant to Section 1013 of the 

Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003, Public Law 108–173, and Section 

902(a) of the Public Health Service Act, 

42 U.S.C. 299a(a). 

DATES: Submission Deadline on or 

before September 29, 2014. 

ADDRESSES: Online submissions: http:// 

effectivehealthcare.AHRQ.gov/

index.cfm/submit-scientificinformation-packets/. Please select the 

study for which you are submitting 

information from the list to upload your 

documents. Email submissions: SIPS@

epc-src.org. 

Print Submissions 

Mailing Address: Portland VA 

Research Foundation, Scientific 

Resource Center, ATTN: Scientific 

Information Packet Coordinator, P.O. 

Box 69539, Portland, OR 97239. 

Shipping Address (FedEx, UPS, etc.): 

Portland VA Research Foundation, 

Scientific Resource Center, ATTN: 

Scientific Information Packet 

Coordinator, 3710 SW U.S. Veterans 

Hospital Road, Mail Code: R&D 71, 

Portland, OR 97239. 

FOR FURTHER INFORMATION CONTACT: 

Ryan McKenna, Telephone: 503–220– 

8262 ext. 58653 or Email: SIPS@epcsrc.org. 


wreier-aviles on DSK5TPTVN1PROD with NOTICES